April 2020

Contents

Editorial

• HTB 17 April 2020: CROI 2020 and COVID-19 supplement

Supplements

• U=U resources for UK clinics: free posters, postcards and factsheets

Conference reports

• Conference on Retroviruses and Opportunistic Infections (CROI 2020)

• Predicted diabetes risk with first-line ART regimens: results from the ADVANCE trial

• Dolutegravir-based ART is safe and effective for pregnant women: first results from the VESTED trial

• A step forward for AAV-mediated delivery of bNAbs

• 10th International Workshop of HIV & Women

• No neural tube defects among pregnancies with periconception dolutegravir exposure in the Dolomite-EPPICC cohort study

Side effects

• Dolutegravir associated with hyperglycaemia in people switching first-line ART in Uganda

HIV prevention and transmission

• PrEP recommended by NHS England (at last)

COVID-19: HIV and COVID-19 coinfection

• Why it is important to include HIV status and HIV testing in managing COVID-19

• COVID-19 symptoms in HIV positive people similar to general population in Wuhan 

• Case study of COVID-19 in HIV positive person with history of HCV

• Case series of five HIV positive people diagnosed with COVID-19 in Spain

COVID-19: vaccine research

• COVID-19 vaccine study opens for recruitment in UK

• US NIH vaccine chief optimistic on prospects for SARS-CoV-2 vaccine

• Sanofi and GSK collaborate on COVID-19 vaccine

• Trial trackers for coronavirus vaccine studies

COVID-19: treatment access

• Potential treatments for COVID-19 could be manufactured for $1 a day or less

• MSF calls for no patents or profiteering on COVID-19 drugs, tests, and vaccines in pandemic

• BASHH responses to impact of COVID-19 on sexual health services

COVID-19: investigational drugs

• Remdesivir for COVID-19: first results from compassionate access programme

• No benefit of hydroxychloroquine and azithromycin in people hospitalised with COVID-19

• High-dose chloroquine study for COVID-19 stopped with worse outcomes: high risk of cardiovascular events

• Gilead expand UK sites for two phase-3 studies of remdesivir to treat COVID-19

COVID-19: pathogenesis

• A clinical-therapeutic staging proposal for COVID-19

COVID-19: guidelines

• Evidence review for treatment: IDSA guidelines for COVID-19

COVID-19: transmission & prevention

• COVID-19 prophylaxis using TDF/FTC and low-dose hydroxychloroquine in Spanish health workers

• Four papers on CoV-2 transmission

• Studies stoke concern about coronavirus contagion through air via speech

• FDA reduces restrictions on gay men donating blood in the US due to COVID-19

• CoV-2 identified in blood donations in China

• Harm reduction for people who inject drugs and for people in prison

COVID-19: research studies

• Community survey on impact of COVID-19 and chemsex

• Prospective cohorts to study COVID-19 including HIV

• European rapid community assessment reports for COVID-19

• COVID-19: medRxiv and bioRxiv websites

COVID-19: other news

• COVID-19 and threats to human rights: another HIV parallel

COVID-19: on the web

• Resources from WHO on COVID-19

• Comparing HIV/AIDS and COVID-19 pandemics

• New COVID-19 webinars

PDFs

• 17 April 2020 vol 21 no 5